CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,453,000 | 8,586,000 | 8,196,000 | 12,945,000 | 9,408,000 |
| Marketable Securities | 2,145,000 | 2,407,000 | 3,259,000 | 2,778,000 | 3,117,000 |
| Receivables | 39,779,000 | 36,469,000 | 35,227,000 | 27,276,000 | 24,431,000 |
| Inventories | 19,246,000 | 18,107,000 | 18,025,000 | 19,090,000 | 17,760,000 |
| Other current assets | 5,091,000 | 3,076,000 | 3,151,000 | 3,544,000 | 5,292,000 |
| TOTAL | $74,714,000 | $68,645,000 | $67,858,000 | $65,633,000 | $60,008,000 |
| Non-Current Assets | |||||
| PPE Net | 13,083,000 | 12,993,000 | 13,183,000 | 12,873,000 | 12,896,000 |
| Investments And Advances | 32,669,000 | 28,934,000 | 23,019,000 | 21,096,000 | 23,025,000 |
| Intangibles | 110,986,000 | 118,595,000 | 120,506,000 | 102,953,000 | 108,147,000 |
| Other Non-Current Assets | 22,086,000 | 24,048,000 | 25,162,000 | 25,720,000 | 28,923,000 |
| TOTAL | $178,824,000 | $184,570,000 | $181,870,000 | $162,642,000 | $172,991,000 |
| Total Assets | $253,538,000 | $253,215,000 | $249,728,000 | $228,275,000 | $232,999,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,068,000 | 5,743,000 | 2,972,000 | 1,778,000 | 4,205,000 |
| Accounts payable and accrued liabilities | 59,384,000 | 55,122,000 | 49,820,000 | 44,403,000 | 38,682,000 |
| Accrued Expenses | 22,387,000 | 20,810,000 | 23,515,000 | 18,745,000 | 17,670,000 |
| Other current liabilities | 1,116,000 | 1,183,000 | 1,141,000 | 2,817,000 | 5,604,000 |
| TOTAL | $88,692,000 | $84,609,000 | $79,189,000 | $69,421,000 | $67,807,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 60,502,000 | 60,527,000 | 58,638,000 | 50,476,000 | 51,971,000 |
| Other Non-Current Liabilities | 25,170,000 | 28,571,000 | 30,930,000 | 32,577,000 | 31,582,000 |
| TOTAL | $89,464,000 | $92,876,000 | $93,903,000 | $87,085,000 | $89,811,000 |
| Total Liabilities | $178,156,000 | $177,485,000 | $173,092,000 | $156,506,000 | $157,618,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,272,211 | 1,260,795 | 1,258,450 | 1,284,112 | 1,312,510 |
| Common Shares | 50,402,000 | 49,661,000 | 48,992,000 | 48,193,000 | 47,377,000 |
| Retained earnings | 61,196,000 | 62,837,000 | 61,604,000 | 56,398,000 | 54,906,000 |
| Other shareholders' equity | 574,000 | 50,000 | -122,000 | -964,000 | 1,271,000 |
| TOTAL | $75,382,000 | $75,730,000 | $76,636,000 | $71,769,000 | $75,381,000 |
| Total Liabilities And Equity | $253,538,000 | $253,215,000 | $249,728,000 | $228,275,000 | $232,999,000 |